Sermorelin, ipamorelin, and tesamorelin all stimulate your body’s own growth hormone production, but each works differently and fits different goals. If you’re comparing them to understand your options, sermorelin is the one available through Telezen MD, prescribed for patients who qualify after a medical evaluation.
1. What Are Growth Hormone Secretagogues?
Growth hormone secretagogues (GHS) are a class of compounds that prompt your pituitary gland to release growth hormone on its own. They work differently from direct HGH injections, which introduce synthetic hormone into your body. GHS work with your existing physiology instead of bypassing it.
As you age, your body’s natural growth hormone output declines steadily after your mid-30s. That decline connects to shifts in body composition, energy, sleep quality, and recovery. Growth hormone peptides are one way clinicians address that gap while preserving your body’s own regulatory signals.
Three peptides come up most often in clinical practice: sermorelin, ipamorelin, and tesamorelin. Here is how they compare.
2. How Each Peptide Works
Sermorelin
Sermorelin is a synthetic version of the first 29 amino acids of growth hormone-releasing hormone (GHRH), the signal your hypothalamus naturally sends to your pituitary gland. It binds to GHRH receptors and triggers a pulse of growth hormone that mirrors your body’s natural rhythm.
Because it works with your existing hormonal feedback loops, sermorelin does not push growth hormone into supraphysiological territory. The release is controlled and pulsatile, reflecting the body’s natural patterns rather than overriding them. This is considered a key advantage over direct HGH administration for most patients.
Ipamorelin
Ipamorelin takes a different route. It is a ghrelin mimetic, meaning it activates the growth hormone secretagogue receptor (GHSR) rather than the GHRH receptor. These are two completely separate pathways for triggering GH release from the pituitary gland.
What makes ipamorelin stand out is its selectivity. Studies show it does not significantly raise cortisol, prolactin, or ACTH at standard doses. You get a targeted GH spike without the hormonal noise that older growth hormone secretagogues like GHRP-2 and GHRP-6 tend to produce.
Ipamorelin has a longer half-life than sermorelin (approximately 2 to 3 hours vs. 11 to 12 minutes), and it can be combined with a GHRH peptide to produce synergistic GH release through two complementary receptor pathways at once. On its own, it is a solid option for sleep quality and recovery support.
Tesamorelin
Tesamorelin is a stabilized, 44-amino-acid analog of GHRH. It binds to the same receptors as sermorelin but has a longer half-life of 26 to 38 minutes, due to structural modifications that make it more resistant to enzymatic breakdown.
Tesamorelin is the only growth hormone-stimulating peptide with FDA approval. That approval is specific: it is indicated for reducing excess visceral fat in HIV-positive patients with lipodystrophy. Phase III clinical trials showed approximately a 15% reduction in visceral adipose tissue in that population, a result not replicated by sermorelin in comparable studies.
Outside of that approved indication, tesamorelin is used off-label at some clinics. It requires more careful monitoring and carries a substantially higher cost than either sermorelin or ipamorelin.
3. Sermorelin vs Ipamorelin vs Tesamorelin: Side-by-Side Comparison
| Feature | Sermorelin | Ipamorelin | Tesamorelin |
|---|---|---|---|
| Peptide class | GHRH analog | GHRP (ghrelin mimetic) | GHRH analog |
| Amino acids | 29 | 5 | 44 |
| Half-life | ~11-12 minutes | ~2-3 hours | ~26-38 minutes |
| Receptor target | GHRH receptor | GHSR (ghrelin receptor) | GHRH receptor |
| Effect on cortisol | Minimal | No significant change | Minimal |
| Primary clinical use | GH optimization, anti-aging, sleep, body composition | Recovery, sleep, GH optimization without cortisol impact | Visceral fat reduction (FDA-approved for HIV lipodystrophy) |
| FDA status | Not approved; compounded | Not approved; compounded | Approved for HIV lipodystrophy only |
| Est. monthly cost | $200-$500 | $150-$600 | Up to $3,000 |
| Available at Telezen MD | Yes | No | No |
4. What Each Peptide Is Best For
Sermorelin: Balanced Growth Hormone Support
Sermorelin fits patients looking for a steady, physiologically consistent approach to growth hormone optimization. It is well-studied, well-tolerated, and among the most accessible peptides in clinical practice.
Published research supports improvements in lean body mass, reductions in fat mass, better sleep quality, and faster recovery. It works best as a long-term protocol, with most patients seeing meaningful changes after several weeks to months of consistent use.
For patients seeking overall wellness support, including body composition, energy, and sleep, sermorelin is the most broadly appropriate starting point among the three peptides.
Ipamorelin: Clean and Selective GH Stimulus
Ipamorelin is a strong option when the goal is a targeted, clean GH pulse without affecting stress hormones. Its receptor selectivity makes it particularly well-suited for patients who are sensitive to cortisol fluctuations or who are managing other hormonal conditions.
Many clinical protocols pair ipamorelin with a GHRH peptide to activate both receptor pathways simultaneously, producing GH release greater than either compound alone. On its own, ipamorelin is commonly used for sleep quality and recovery.
Ipamorelin is not available through Telezen MD, but understanding it is helpful if you are comparing your options across providers.
Tesamorelin: Targeted for Visceral Fat in Specific Populations
Tesamorelin’s clinical evidence is strongest for visceral fat reduction in HIV-positive patients with lipodystrophy. That is the specific application it was developed and approved for.
For general metabolic or wellness use, the evidence base is thinner, and the monthly cost is significantly higher than either alternative, sometimes reaching $3,000 per month. Off-label use requires monitoring for joint pain, transient blood glucose elevation, and water retention.
Tesamorelin is not available through Telezen MD.
5. Why Telezen MD Prescribes Sermorelin
Telezen MD works with patients on growth hormone optimization through a focused, medically supervised protocol. Sermorelin is prescribed because it has an established clinical profile, is appropriate for subcutaneous self-injection in an outpatient setting, and supports natural GH rhythms without disrupting the body’s own feedback system.
Your medication is compounded by 503A FDA-regulated pharmacies. That means it is formulated to your specific prescription and produced under strict pharmacy standards.
The process is straightforward. You complete an online intake with your medical history and choose a plan. After you submit, the Telezen MD medical team reviews your information within 24 hours and, if you qualify, issues a prescription. Your medication ships directly to your door.
Learn more about how sermorelin injections work at Telezen MD: sermorelin injections. For a deeper look at the therapy, visit our complete sermorelin therapy guide.
Frequently Asked Questions
Is sermorelin or ipamorelin better for fat loss?
Both can support fat loss through improved growth hormone levels, but neither is specifically indicated for fat reduction as a standalone outcome. Tesamorelin has the strongest clinical evidence for visceral fat reduction in a defined patient population (HIV-associated lipodystrophy). For general body composition support, sermorelin is the most widely used option at clinics like Telezen MD.
Can sermorelin and ipamorelin be combined?
Yes. Some clinical protocols use a GHRH peptide like sermorelin alongside a GHRP like ipamorelin to stimulate GH release through two separate receptor pathways at the same time. This can produce a more pronounced GH response. Telezen MD’s current protocol uses sermorelin as a standalone therapy.
How long does sermorelin take to work?
Most patients notice early improvements in sleep quality within the first few weeks. Body composition changes, including shifts in fat mass and lean tissue, typically develop over several weeks to months of consistent use. Results vary based on individual factors including baseline health, diet, and activity level.
Is tesamorelin FDA-approved for anti-aging or weight loss?
No. Tesamorelin’s FDA approval is specifically limited to reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. Its use for anti-aging, general weight management, or other purposes is off-label and not FDA-approved.
What is the difference between a GHRH peptide and a GHRP?
GHRH peptides like sermorelin and tesamorelin mimic your hypothalamus’s natural growth hormone-releasing hormone, binding to GHRH receptors on the pituitary gland. GHRPs like ipamorelin mimic ghrelin and work through a separate receptor called GHSR. Both pathways trigger GH release, but through different mechanisms. Using both types together can produce synergistic effects.
Who is a candidate for sermorelin at Telezen MD?
Candidates are patients who complete an online intake, provide their medical history, and are reviewed by the Telezen MD medical team. Sermorelin is not appropriate for everyone. Your provider determines eligibility based on your individual health profile during the review process.
The Bottom Line
Sermorelin, ipamorelin, and tesamorelin each occupy a distinct place in the growth hormone peptide landscape. Tesamorelin is the most clinically specific, with FDA approval for visceral fat reduction in a defined population and a much higher price point. Ipamorelin offers a clean, selective GH pulse with minimal impact on other hormones. Sermorelin provides steady, physiologically appropriate GH support that fits a wide range of wellness and body composition goals.
If sermorelin fits what you are looking for, Telezen MD makes the process straightforward. Complete your intake online and the medical team will review your history within 24 hours. Start here: telezenmd.com/sermorelin-injections.
Sources
- Prakash A, Goa KL. Sermorelin: A Review of Its Use in the Diagnosis and Treatment of Children with Idiopathic Growth Hormone Deficiency. BioDrugs. 1999;12(2):139-157. https://pubmed.ncbi.nlm.nih.gov/18031077/
- Falutz J, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat. J Acquir Immune Defic Syndr. 2010;53(3):311-322. https://pubmed.ncbi.nlm.nih.gov/20101178/
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. https://pubmed.ncbi.nlm.nih.gov/9849822/
- U.S. Food and Drug Administration. Egrifta (tesamorelin for injection) Prescribing Information. FDA.gov
- Veldhuis JD, et al. Growth hormone-releasing hormone and growth hormone secretagogues in normal aging. Endocrine. 2005;26(2):155-163. https://pubmed.ncbi.nlm.nih.gov/15888937/
Disclaimer
This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Telezen MD services are available only to patients who qualify following an online medical evaluation with a licensed healthcare provider. Results vary by individual. Compounded medications prescribed through Telezen MD are compounded by 503A FDA-regulated pharmacies. Compounded medications are not reviewed or approved by the FDA for safety or efficacy. Statements on this page have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before beginning any new medical treatment. If you experience any adverse effects, contact your provider immediately.
